Susan Pandya

Susan Pandya currently serves as a Board Director at MOMA Therapeutics since February 2025. Previously, Susan held significant roles at Servier Pharmaceuticals from April 2021 to October 2024, including Global Head of Oncology Clinical Development Late Stage and LCM, and Vice President Clinical Development, where Susan led clinical development efforts for various Hematology and Oncology assets across multiple phases. At Agios Pharmaceuticals, Susan advanced through roles including Vice President Clinical Development and Senior Medical Director, focusing on Hematology and Oncology indications. Earlier experience includes serving as Senior Director of Medical Research at Acceleron Pharma and Independent Physician Reviewer at WorldCare Clinical, LLC. Susan completed a fellowship in Hematology/Oncology and an Internal Medicine residency at Harvard Medical School, achieving board certifications in both fields.